Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease.

[1]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[2]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[3]  Jeroen J. Bax,et al.  Prognostic value of dobutamine stress echocardiography in patients with diabetes. , 2003, Diabetes care.

[4]  M. Lauer,et al.  Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. , 2002, Diabetes care.

[5]  S. Sawada,et al.  Prognostic value of a negative stress echocardiographic study in diabetic patients. , 2002, American heart journal.

[6]  Jeroen J. Bax,et al.  Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. , 2001, Diabetes care.

[7]  P. Pellikka,et al.  Prognostic stratification of diabetic patients by exercise echocardiography. , 2001, Journal of the American College of Cardiology.

[8]  E. Damsgaard,et al.  Cardiovascular autonomic neuropathy in insulin-dependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. , 2000, Journal of internal medicine.

[9]  R. Gougeon,et al.  Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes. , 2000, Diabetes care.

[10]  E J Topol,et al.  Cause of death in clinical research: time for a reassessment? , 1999, Journal of the American College of Cardiology.

[11]  F. Logerfo,et al.  Diabetes and peripheral vascular disease. , 1999, Journal of vascular surgery.

[12]  R. Califf,et al.  Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). , 1999, Circulation.

[13]  Jeroen J. Bax,et al.  Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. , 1998, Diabetes care.

[14]  M. Laakso,et al.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.

[15]  T. Sherwood.  Lancet ombudsman's first report , 1997, The Lancet.

[16]  D. Singer,et al.  The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is … or is it? , 1997, The Lancet.

[17]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[18]  B. Davis,et al.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.

[19]  M. Winniford,et al.  Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. , 1995, Circulation.

[20]  H. Parving,et al.  Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V , 1994, Diabetes Care.

[21]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[22]  E. Picano,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography , 1993 .

[23]  J. Neaton,et al.  Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.

[24]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[25]  E. Ford,et al.  Risk factors for mortality from all causes and from coronary heart disease among persons with diabetes. Findings from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. , 1991, American journal of epidemiology.

[26]  M. Koistinen.  Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. , 1990, BMJ.

[27]  E. Picano,et al.  High dose dipyridamole echocardiography test in effort angina pectoris. , 1986, Journal of the American College of Cardiology.